Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anila Cara

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|November 6, 2024
[Hypoxia-Inducible Factor Prolyl Hydroxylase Enzyme Inhibitors: A Novel Therapy for Anemia Treatment in CKD Patients]Andrea Stucchi, Lorenza Magagnoli, Anila Cara, et al.
International Journal of Cardiology|November 7, 2022
Do SGLT2 inhibitors protect elderly patients from HF rehospitalization and CKD progression? More opportunities than concernsAndrea Galassi, Anila Cara, Lorenza Magagnoli, et al.
Mayo Clinic Proceedings|March 6, 2026
Cancer Incidence and Risk Factors in PLA2R-Associated Membranous NephropathyIlario Russo, Maria J Vargas-Brochero, Anila Cara, et al.
Mayo Clinic Proceedings|June 15, 2026
In Reply: Reassessing Cancer Attribution and Methodological Limitations in PLA2R-Associated Membranous NephropathyIlario Russo, Maria J Vargas-Brochero, Anila Cara, et al.
Blood Purification|July 20, 2025
Association between Blood Flow Measured within 30 Days from Arteriovenous Access Creation and Thrombosis RiskGiacomo Scherini, Lorenza Magagnoli, Anila Cara, et al.
Expert Opinion on Drug Safety|May 17, 2021
Current treatment options for secondary hyperparathyroidism in patients with stage 3 to 4 chronic kidney disease and vitamin D deficiencyAndrea Galassi, Paola Ciceri, Giulia Porata, et al.
Expert Opinion on Pharmacotherapy|September 30, 2023
Future treatment of vascular calcification in chronic kidney diseaseMario Cozzolino, Federico Maffei Faccioli, Anila Cara, et al.
Kidney International Reports|August 15, 2025
Long-term Outcome of Adult Patients With Membranous Nephropathy Treated With RituximabMaria J Vargas-Brochero, Elisabeth Lafaut, Yeshwanter Radhakrishnan, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 25, 2025
Antiproteinuric effect of SGLT2 inhibitors in non-diabetic glomerulopathies is dependent on body mass indexMaria J Vargas-Brochero, Ilario Russo, Tommaso Mazzierli, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|November 6, 2024
[Hypoxia-Inducible Factor Prolyl Hydroxylase Enzyme Inhibitors: A Novel Therapy for Anemia Treatment in CKD Patients]Andrea Stucchi, Lorenza Magagnoli, Anila Cara, et al.
International Journal of Cardiology|November 7, 2022
Do SGLT2 inhibitors protect elderly patients from HF rehospitalization and CKD progression? More opportunities than concernsAndrea Galassi, Anila Cara, Lorenza Magagnoli, et al.
Mayo Clinic Proceedings|March 6, 2026
Cancer Incidence and Risk Factors in PLA2R-Associated Membranous NephropathyIlario Russo, Maria J Vargas-Brochero, Anila Cara, et al.
Mayo Clinic Proceedings|June 15, 2026
In Reply: Reassessing Cancer Attribution and Methodological Limitations in PLA2R-Associated Membranous NephropathyIlario Russo, Maria J Vargas-Brochero, Anila Cara, et al.
Blood Purification|July 20, 2025
Association between Blood Flow Measured within 30 Days from Arteriovenous Access Creation and Thrombosis RiskGiacomo Scherini, Lorenza Magagnoli, Anila Cara, et al.
Expert Opinion on Drug Safety|May 17, 2021
Current treatment options for secondary hyperparathyroidism in patients with stage 3 to 4 chronic kidney disease and vitamin D deficiencyAndrea Galassi, Paola Ciceri, Giulia Porata, et al.
Expert Opinion on Pharmacotherapy|September 30, 2023
Future treatment of vascular calcification in chronic kidney diseaseMario Cozzolino, Federico Maffei Faccioli, Anila Cara, et al.
Kidney International Reports|August 15, 2025
Long-term Outcome of Adult Patients With Membranous Nephropathy Treated With RituximabMaria J Vargas-Brochero, Elisabeth Lafaut, Yeshwanter Radhakrishnan, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 25, 2025
Antiproteinuric effect of SGLT2 inhibitors in non-diabetic glomerulopathies is dependent on body mass indexMaria J Vargas-Brochero, Ilario Russo, Tommaso Mazzierli, et al.
Pageof 1